"Leaders in Digestive Health Since 1996. 93+ Gastroenterologists | 60+ North Texas Locations"

During the past decade, Digestive Health Associates of Texas conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Digestive Health Associates of Texas" #1 sponsor was "Celgene" with 3 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Pacific Health Foundation" with 2 trials sponsored, "Altheus Therapeutics, Inc." with 1 trials sponsored and "Arena Pharmaceuticals" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Digestive Health Associates of Texas" #1 collaborator was "American Society for Gastrointestinal Endoscopy" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Digestive Health Associates of Texas" are "Ulcerative Colitis" (5 trials), "Eosinophilic Esophagitis" (2 trials), "Asian Americans" (1 trials), "Chronic Hepatitis C" (1 trials) and "Common Bile Duct Stricture" (1 trials). Many other conditions were trialed in "Digestive Health Associates of Texas" in a lesser frequency.

Most popular intervention types in "Digestive Health Associates of Texas" are "Drug" (16 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "CC-93538" (2 trials), "Mirikizumab" (2 trials), "12 weeks SOF/LED" (1 trials) and "8 weeks SOF/LED" (1 trials). Other intervention names were less common.

The vast majority of trials in "Digestive Health Associates of Texas" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Digestive Health Associates of Texas". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Digestive Health Associates of Texas, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Digestive Health Associates of Texas, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".